Cargando…
mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci
The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of cell growth that is often aberrantly activated in cancer. However, mTORC1 inhibitors, such as rapamycin, have limited effectiveness as single agent cancer therapies, with feedback mechanisms inherent to the signaling ne...
Autores principales: | Kelsey, Ilana, Zbinden, Marie, Byles, Vanessa, Torrence, Margaret, Manning, Brendan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701013/ https://www.ncbi.nlm.nih.gov/pubmed/29170467 http://dx.doi.org/10.1038/s41598-017-16398-y |
Ejemplares similares
-
Oncogenic signaling upstream of mTORC1 drives lipogenesis and proliferation through SREBP
por: Ricoult, Stéphane, et al.
Publicado: (2014) -
SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth
por: Porstmann, Thomas, et al.
Publicado: (2008) -
Pim-2 kinase inhibits inflammation by suppressing the mTORC1 pathway in atherosclerosis
por: Liao, Minqi, et al.
Publicado: (2021) -
Hepatic mTORC1 signaling activates ATF4 as part of its metabolic response to feeding and insulin
por: Byles, Vanessa, et al.
Publicado: (2021) -
Mechanisms and consequences of hepatic regulation of mTORC1 by metformin
por: Howell, Jessica J, et al.
Publicado: (2014)